Search Results
Search results for "GPCR data platform"
Results found for "GPCR data platform"
- Carola Weiss joins InterAx Biotech AG as VP Business Development
Read more at the source #DrGPCR #GPCR #IndustryNews
- Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards
Read more at the source #DrGPCR #GPCR #IndustryNews
- Discovery of 3(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligand
August 2022 "Abstract Sigma receptor is a transmembrane non-GPCR protein expressed mainly in the endoplasmic Read more at the source #DrGPCR #GPCR #IndustryNews
- Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Neurotransmitters: Potential Targets in Glioblastoma
Read more at the source #DrGPCR #GPCR #IndustryNews
- Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of...
Despite its high mechanistic complexity, the modularized QSP platform can be readily reproduced, expanded Read more at the source #DrGPCR #GPCR #IndustryNews
- 2nd IRN i-GPCRnet, September 30 to October 1st, 2022. University of Wurzburg, Germany
Read more at the source #DrGPCR #GPCR #IndustryNews
- Tectonic Therapeutic Strengthens Leadership Team
Tectonic Therapeutic, Inc. a pre-clinical stage biotechnology company transforming the discovery of novel GPCR-targeted Read more at the source #DrGPCR #GPCR #IndustryNews
- Naggie and Rajagopal Elected Members of American Society for Clinical Investigation
" Read more at the source #DrGPCR #GPCR #IndustryNews
- Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...
clinical success Agreement to utilize Exscientiaâs AI-based capabilities and personalised medicine platform small molecule candidates across oncology and immunology, leveraging Exscientiaâs end-to-end AI-driven platform Read more at the source #DrGPCR #GPCR #IndustryNews
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
Read more at the source #DrGPCR #GPCR #IndustryNews
- ChemoCentryx Announces EU Approval of TAVNEOSÂŽ (avacopan) for the Treatment of ANCA-Associated ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
media at 16:00 CET (15:00 GMT / 10:00 EST / 07:00 PST) the same day. " Read more at the source #DrGPCR #GPCR
- Discovery On Target, October 17-20, 2022, Boston, USA
Read more at the source #DrGPCR #GPCR #IndustryNews
- Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response
Read more at the source #DrGPCR #GPCR #IndustryNews
- Chemerin Forms: Their Generation and Activity
Read more at the source #DrGPCR #GPCR #IndustryNews
- Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Structure of Mycobacterium tuberculosis Cya, an evolutionary ancestor of the mammalian membrane...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Identification of hub genes in the subacute spinal cord injury in rats
Finally, the relative mRNA expression level of central genes was verified by RT-PCR." Read more at the source #DrGPCR #GPCR #IndustryNews
- Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
March 2022 "Explicyte grants Domain Therapeutics exclusivity on data related to GPCR implicated in immunoresistance company specializing in the discovery and development of new drugs targeting G Protein-Coupled Receptors (GPCRs The two companies will combine their expertise to identify GPCR targets and associated biomarkers to Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Reports Second Quarter 2022 Results and Provides Business Update
Read more at the source #DrGPCR #GPCR #IndustryNews
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
antagonist of the arginine-vasopressin V2 receptor (V2R) and the only unique Kunitz-type peptide active on a GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
Read more at the source #DrGPCR #GPCR #IndustryNews
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
Read more at the source #DrGPCR #GPCR #IndustryNews
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
Read more at the source #DrGPCR #GPCR #IndustryNews
- Primary cilia and SHH signaling impairments in human and mouse models of Parkinsonâs disease
Read more at the source #DrGPCR #GPCR #IndustryNews
- C3aR plays both sides in regulating resistance to bacterial infections
Read more at the source #DrGPCR #GPCR #IndustryNews
- Amgen to Acquire Chemocentryx for $4 Billion in Cash
Read more at the source #DrGPCR #GPCR #IndustryNews
- Sweet taste receptor agonists attenuate macrophage ILâ1β expression and eosinophilic inflammation...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Immunomodulatory Role of Neuropeptides in the Cornea
Read more at the source #DrGPCR #GPCR #IndustryNews
